Dr. James said that she receives research funding from CSL Behring and Grifols. She is also a member of the von Willebrand disease medical advisory board sponsored by CSL Behring, Octapharma, and Baxter.
EXPERT ANALYSIS FROM THE ANNUAL MEETING OF THE NORTH AMERICAN SOCIETY FOR PEDIATRIC AND ADOLESCENT GYNECOLOGY